Literature DB >> 9729533

Low relative frequencies of CD26(+) CD4(+) cells in long-term nonprogressing human immunodeficiency virus type 1-infected subjects.

C Broström1, A Sönnerborg, S Lindbäck, H Gaines.   

Abstract

A broad antibody panel was used for immunophenotyping of human immunodeficiency virus type 1 (HIV-1)-infected patients who were long-term nonprogressors (LTNP). The LTNP were compared with patients in the early phase of infection and patients who had progressed to advanced immunodeficiency. Changes in CD8(+) subset distribution were observed mainly at acquisition of HIV-1 infection, whereas CD4(+) subset changes appeared during progression of HIV-1 infection. The decreasing levels of CD4(+) cells were characterized by an increasing frequency of cells expressing the activation markers HLA-Dr and CD45RO but not the CD28 surface antigen. The LTNP exhibited significant changes compared to HIV-negative patients in almost all markers. Compared to patients in the early phase of infection, the only difference was a relatively lower frequency of CD4(+) cells expressing CD26 among the LTNP. The results show that HIV-1-infected persons who have no signs of immunodeficiency despite many years of infection have an immunophenotypic pattern that is substantially different from that of noninfected persons. Despite the long duration of infection, the LTNP exhibit a pattern similar to that of newly infected persons, with the exception of lower expression of CD26 on CD4(+) cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729533      PMCID: PMC95637          DOI: 10.1128/CDLI.5.5.662-666.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  21 in total

1.  Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology.

Authors:  P Pehrson; S Lindbäck; C Lidman; H Gaines; J Giesecke
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

2.  Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase.

Authors:  M Hegen; J Kameoka; R P Dong; S F Schlossman; C Morimoto
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 3.  Role of CD26 for CD4 memory T cell function and activation.

Authors:  R P Dong; C Morimoto
Journal:  Hum Cell       Date:  1996-09       Impact factor: 4.174

4.  Non-progression in HIV infection.

Authors:  P J Easterbrook
Journal:  AIDS       Date:  1994-08       Impact factor: 4.177

5.  CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients.

Authors:  A Mocroft; M Bofill; M Lipman; E Medina; N Borthwick; A Timms; L Batista; M Winter; C A Sabin; M Johnson; C A Lee; A Phillips; G Janossy
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-02-01

6.  Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.

Authors:  A R Lifson; S P Buchbinder; H W Sheppard; A C Mawle; J C Wilber; M Stanley; C E Hart; N A Hessol; S D Holmberg
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

7.  CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection.

Authors:  S Zanussi; C Simonelli; M D'Andrea; C Caffau; M Clerici; U Tirelli; P DePaoli
Journal:  Clin Exp Immunol       Date:  1996-08       Impact factor: 4.330

8.  Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons.

Authors:  M Vesanen; C E Stevens; P E Taylor; P Rubinstein; K Saksela
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

9.  Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.

Authors:  G Pantaleo; S Menzo; M Vaccarezza; C Graziosi; O J Cohen; J F Demarest; D Montefiori; J M Orenstein; C Fox; L K Schrager
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

10.  Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.

Authors:  M Bofill; A Mocroft; M Lipman; E Medina; N J Borthwick; C A Sabin; A Timms; M Winter; L Baptista; M A Johnson; C A Lee; A N Phillips; G Janossy
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

View more
  2 in total

1.  Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection.

Authors:  Chris C Ibegbu; Yong-Xian Xu; Dimitri Fillos; Henry Radziewicz; Arash Grakoui; Athena P Kourtis
Journal:  Immunology       Date:  2008-07-22       Impact factor: 7.397

2.  The number of circulating CD26 expressing cells is decreased in critical COVID-19 illness.

Authors:  Joanne T deKay; Teresa L May; Richard R Riker; Jonathan Rud; David J Gagnon; Douglas B Sawyer; David B Seder; Sergey Ryzhov
Journal:  Cytometry A       Date:  2022-03-04       Impact factor: 4.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.